It is also reported that TRIM54 was a novel and sensitive biomarker for the diagnosis of acute myocardial infarction, and heterozygous TRIM54 mutation may contribute to cardiac and skeletal protein aggregate myopathy (26, 27). This evidence concerns the gene TRIM54 and myocardial infarction.